Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Gains from Investment Securities (2020 - 2023)

Terns Pharmaceuticals' Gains from Investment Securities history spans 4 years, with the latest figure at -$37000.0 for Q4 2023.

  • For Q4 2023, Gains from Investment Securities fell 516.67% year-over-year to -$37000.0; the TTM value through Sep 2023 reached $746412.0, down 46.68%, while the annual FY2025 figure was $218000.0, 83.26% down from the prior year.
  • Gains from Investment Securities reached -$37000.0 in Q4 2023 per TERN's latest filing, down from $746412.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $7.7 million in Q1 2023 to a low of -$37000.0 in Q4 2023.
  • Average Gains from Investment Securities over 4 years is $1.4 million, with a median of $955451.0 recorded in 2021.
  • The largest YoY upside for Gains from Investment Securities was 17057.22% in 2023 against a maximum downside of 516.67% in 2023.
  • A 4-year view of Gains from Investment Securities shows it stood at $2.5 million in 2020, then crashed by 52.79% to $1.2 million in 2021, then tumbled by 100.52% to -$6000.0 in 2022, then plummeted by 516.67% to -$37000.0 in 2023.
  • Per Business Quant, the three most recent readings for TERN's Gains from Investment Securities are -$37000.0 (Q4 2023), $746412.0 (Q3 2023), and $26584.0 (Q2 2023).